Summary
The group agreed on the facts
· that unwanted sleep onset has been observed after non-ergot as well as ergot dopamine agonists,
· that patients on these drugs need to be warned,
· that patients who have experienced sleepiness already must not drive a car unless the dosage is lowered and sleepines has vanished,
· that a genetic predisposition for narcoleptic cataplexy has to be ruled out,
· that predictors of so-called sleep attacks need to be explored individually with the help of sleepiness scales and collectively in a carefull study, respectively.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clarenbach, P., Greulich, W., Meinck, H. et al. Workshop I: Parkinson's disease and sleep – results of the group discussion. J Neurol 247 (Suppl 4), IV34–IV35 (2000). https://doi.org/10.1007/PL00007773
Issue Date:
DOI: https://doi.org/10.1007/PL00007773